OncoPharm
OncoPharm
John Bossaer
Adjuvant HD Cisplatin-RT For High Risk Head & Neck Cancer
17 minutes Posted May 5, 2022 at 6:03 pm.
0:00
17:04
Download MP3
Show notes
The Landmarks of OncoPharm series returns to discuss 2 landmark studies (and 1 editorial) in head & neck cancer.
Editorial: https://ascopubs.org/doi/pdf/10.1200/JCO.22.00274
EUORTC Study: https://www.nejm.org/doi/full/10.1056/NEJMoa032641
Intergroup Study: https://www.nejm.org/doi/full/10.1056/NEJMoa032646